Our data also concur with studies that used IL-27-transduced cancer cell lines, including colon carcinoma [16], TBJ neuroblastoma [14], [38] and B16F10 melanoma [17], [18], [37], [39], which showed that induced IL-27 expression, from tumor tissue itself, enhanced the protective immune response. The gene discussed is IL27; the disease is melanoma.